The purpose of this clinical trial is to evaluate the effect of different central venous catheter dressing methods on the development of medical device-related pressure injuries in participants treated in the intensive care unit. This study aims to answer the following questions: * What is the risk of pressure injury development in participants whose catheter dressings are performed using gauze and adhesive tape? * What is the risk of pressure injury development in participants whose catheter dressings are performed using a chlorhexidine gluconate-containing transparent dressing? * Is there a difference between these two dressing methods in terms of pressure injury development? The researchers will compare participants receiving gauze and adhesive tape dressings with participants receiving chlorhexidine gluconate-containing transparent dressings. Participants will: * Receive catheter dressings according to the assigned dressing method based on randomization. * Undergo regular catheter site assessments. * Be evaluated for pressure injury development through skin assessments. * Have their pressure injury risk monitored using the Braden Pressure Injury Risk Assessment Scale.
This study is a randomized controlled experimental study designed to evaluate the effects of different central venous catheter dressing methods on the development of medical device-related pressure injuries in participants treated in the intensive care unit. The study was conducted in the intensive care unit of a tertiary-level hospital. Participants who underwent central venous catheterization and met the study protocol criteria were included. Participants were assigned to two groups using a randomization method. The randomization process was performed to ensure balanced group distribution and to minimize potential bias. In the first group, central venous catheter dressing was performed using gauze and adhesive tape. In the second group, dressing was performed using a chlorhexidine gluconate-containing transparent dressing. Participants' catheter sites were systematically assessed at predetermined observation time points. During these assessments, skin integrity, skin surface characteristics, and clinical findings related to medical device-related pressure injury development were evaluated. Catheter site evaluations were recorded using a structured observation form. Moisture at the catheter site and skin surface characteristics were assessed during routine follow-up. Participants' pressure injury risk levels were evaluated using the Braden Pressure Injury Risk Assessment Scale. Throughout the study, central venous catheter care and dressing procedures were performed in accordance with clinical protocols. Data obtained during the study were analyzed using appropriate statistical methods.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
78
Central venous catheter dressing performed using sterile gauze and adhesive tape.
Central venous catheter dressing performed using chlorhexidine gluconate-impregnated transparent dressing.
Prof. Dr. Cemil Taşçıoğlu City Hospital
Istanbul, Istanbul, Turkey (Türkiye)
Medical device-related pressure injury at central venous catheter site.
Incidence of Stage 1 medical device-related pressure injury at the central venous catheter insertion site, assessed according to the National Pressure Injury Advisory Panel (NPIAP) Staging System (Stage 1 represents non-blanchable erythema of intact skin; higher stages indicate greater tissue damage).
Time frame: Day 2, Day 9, and Day 16
Moisture at central venous catheter site
Assessment of moisture status at the central venous catheter insertion site during dressing changes.
Time frame: Day 2, Day 9, and Day 16
Pressure injury risk (Braden Scale)
Pressure injury risk assessed using the Braden Scale for Predicting Pressure Sore Risk (total score range: 6-23; lower scores indicate higher risk of pressure injury).
Time frame: Day 1, Day 2, Day 9, and Day 16
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.